National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting, 14027-14028 [2012-5684]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 46 / Thursday, March 8, 2012 / Notices
14027
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
National Institute of Diabetes and
Digestive and Kidney Diseases
Diabetes Mellitus Interagency
Coordinating Committee; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Topics in
Development, Signaling, and Disease.
Date: April 3, 2012.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, OD, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, NIH, 6100
Executive Blvd., Room 5B01–G, Bethesda,
MD 20892, 301–435–6878, wedeenc@mail.
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; ZHD1 DSR–Z 54.
Date: April 5, 2012.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20892–7510, (301) 435–6902,
peter.zelazowski@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
The Diabetes Mellitus Interagency
Coordinating Committee (DMICC) will
hold a meeting on April 5, 2012, from
8:30 a.m. to 11:30 a.m. at the
Neuroscience Building, Room C, 6001
Executive Boulevard, Rockville, MD
20852. The meeting is open to the
public but attendance is limited to space
available. Non-federal individuals
planning to attend the meeting should
notify the Contact Person listed on this
notice at least 2 days prior to the
meeting. Individuals who plan to attend
and need special assistance, such as
sign language interpretation or other
reasonable accommodations, should
inform the Contact Person listed below
at least 10 days in advance of the
meeting.
The DMICC facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
members to learn about and discuss
current and future diabetes programs in
DMICC member organizations and to
identify opportunities for collaboration.
The April 5, 2012, DMICC meeting will
discuss ‘‘Healthy People 2010 Progress
Report and Healthy People 2020
Objectives.’’
Any member of the public interested
in presenting oral comments to the
Committee should notify the Contact
Person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present
oral comments and presentations will be
limited to a maximum of five minutes.
Both printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
Dated: March 2, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Dated: March 2, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5691 Filed 3–7–12; 8:45 am]
[FR Doc. 2012–5692 Filed 3–7–12; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
VerDate Mar<15>2010
15:20 Mar 07, 2012
Jkt 226001
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
E:\FR\FM\08MRN1.SGM
08MRN1
14028
Federal Register / Vol. 77, No. 46 / Thursday, March 8, 2012 / Notices
meeting, oral comments will be allowed
on a first come, first serve basis.
A registration link and information
about the DMICC meeting will be
available on the DMICC Web site:
www.diabetescommittee.gov . Members
of the public who would like to receive
email notification about future DMICC
meetings could register on a listserv
available on the same Web site.
For further information concerning
this meeting contact Dr. Sanford
Garfield, Executive Secretary of the
Diabetes Mellitus Interagency
Coordinating Committee, National
Institute of Diabetes and Digestive and
Kidney Diseases, 6707 Democracy
Boulevard, Room 654, MSC 5460,
Bethesda, MD 20892–5460, Telephone:
301- 594–8803 Fax: 301–402–6271,
Email: dmicc@mail.nih.gov.
Dated February 28, 2012.
Sanford Garfield,
Executive Secretary, DMICC, Division of
Diabetes, Endocrinology and Metabolic
Diseases, NIDDK, National Institutes of
Health.
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Rm 3134, Bethesda, MD 20892–7616, 301–
435–2766, rathored@mail.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Innovation for HIV Vaccine
Discovery (R01).
Date: April 25, 2012.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Dharmendar Rathore,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Rm 3134, Bethesda, MD 20892–7616, 301–
435–2766, rathored@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 1, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5684 Filed 3–7–12; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2012–5710 Filed 3–7–12; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Innovation for HIV Vaccine
Discovery (R01).
Date: April 3, 2012.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Dharmendar Rathore,
Ph.D., Scientific Review Officer, Scientific
VerDate Mar<15>2010
15:20 Mar 07, 2012
Jkt 226001
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Oncological Sciences.
Date: March 26–29, 2012.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Inese Z. Beitins, MD,
Scientific Review Officer, Center for
PO 00000
Frm 00030
Fmt 4703
Sfmt 9990
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7892, Bethesda, MD 20892, 301–435–
1034, beitinsi@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Biological
Chemistry and Macromolecular Biophysics
A.
Date: April 3–4, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Nuria E. Assa-Munt, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4164,
MSC 7806, Bethesda, MD 20892, (301) 451–
1323, assamunu@csr.nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; International and Cooperative
Projects—1 Study Section.
Date: April 4, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marina del Rey Marriott, 4100
Admiralty Way, Marina del Rey, CA 90292.
Contact Person: Hilary D. Sigmon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, (301) 594–
6377, sigmonh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Mitochondria, Neuronal Injury and
Neurodegeneration.
Date: April 5, 2012.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Laurent Taupenot, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4811,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, taupenol@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: March 1, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5708 Filed 3–7–12; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\08MRN1.SGM
08MRN1
]]>Agencies
[Federal Register Volume 77, Number 46 (Thursday, March 8, 2012)]
[Notices]
[Pages 14027-14028]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5684]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases
Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting
The Diabetes Mellitus Interagency Coordinating Committee (DMICC)
will hold a meeting on April 5, 2012, from 8:30 a.m. to 11:30 a.m. at
the Neuroscience Building, Room C, 6001 Executive Boulevard, Rockville,
MD 20852. The meeting is open to the public but attendance is limited
to space available. Non-federal individuals planning to attend the
meeting should notify the Contact Person listed on this notice at least
2 days prior to the meeting. Individuals who plan to attend and need
special assistance, such as sign language interpretation or other
reasonable accommodations, should inform the Contact Person listed
below at least 10 days in advance of the meeting.
The DMICC facilitates cooperation, communication, and collaboration
on diabetes among government entities. DMICC meetings, held several
times a year, provide an opportunity for members to learn about and
discuss current and future diabetes programs in DMICC member
organizations and to identify opportunities for collaboration. The
April 5, 2012, DMICC meeting will discuss ``Healthy People 2010
Progress Report and Healthy People 2020 Objectives.''
Any member of the public interested in presenting oral comments to
the Committee should notify the Contact Person listed on this notice at
least 10 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present oral
comments and presentations will be limited to a maximum of five
minutes. Both printed and electronic copies are requested for the
record. In addition, any interested person may file written comments
with the Committee by forwarding their statement to the Contact Person
listed on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person. Because of time constraints for
the
[[Page 14028]]
meeting, oral comments will be allowed on a first come, first serve
basis.
A registration link and information about the DMICC meeting will be
available on the DMICC Web site: www.diabetescommittee.gov . Members of
the public who would like to receive email notification about future
DMICC meetings could register on a listserv available on the same Web
site.
For further information concerning this meeting contact Dr. Sanford
Garfield, Executive Secretary of the Diabetes Mellitus Interagency
Coordinating Committee, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 654, MSC 5460,
Bethesda, MD 20892-5460, Telephone: 301- 594-8803 Fax: 301-402-6271,
Email: dmicc@mail.nih.gov.
Dated February 28, 2012.
Sanford Garfield,
Executive Secretary, DMICC, Division of Diabetes, Endocrinology and
Metabolic Diseases, NIDDK, National Institutes of Health.
[FR Doc. 2012-5684 Filed 3-7-12; 8:45 am]
BILLING CODE 4140-01-P
